QuidelOrtho Corp (QDEL) stock
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)
Close on Nov 17, 2026Market cap $676.84MP/E –Yield –
QuidelOrtho EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
QuidelOrtho's EPS for the twelve months ending Sep 27, 2026 was -$5.41. For fiscal 2025 it was -$16.69. The highest annual figure on record is $18.60 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | -$16.69 | – |
| FY2024 | Dec 29, 2024 | -$30.54 | – |
| FY2023 | Dec 31, 2023 | -$0.15 | -101.6% |
| FY2022 | Jan 1, 2023 | $9.56 | -41.8% |
| FY2021 | Jan 2, 2022 | $16.43 | -11.7% |
| FY2020 | Jan 3, 2021 | $18.60 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | -$0.78 | – |
| Q2 FY2026 | Jun 28, 2026 | -$1.36 | – |
| Q1 FY2026 | Mar 29, 2026 | -$1.35 | – |
| Q4 FY2025 | Dec 28, 2025 | -$1.92 | – |
| Q3 FY2025 | Sep 28, 2025 | -$10.78 | – |
| Q2 FY2025 | Jun 29, 2025 | -$3.77 | – |
| Q1 FY2025 | Mar 30, 2025 | -$0.19 | – |
| Q4 FY2024 | Dec 29, 2024 | -$2.64 | -2740.0% |
| Q3 FY2024 | Sep 29, 2024 | -$0.30 | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.20 | – |
| Q1 FY2024 | Mar 31, 2024 | -$25.50 | -3593.2% |
| Q4 FY2023 | Dec 31, 2023 | $0.10 | -64.3% |
| Q3 FY2023 | Oct 1, 2023 | -$0.19 | -152.8% |
| Q2 FY2023 | Jul 2, 2023 | -$0.80 | -107.1% |
| Q1 FY2023 | Apr 2, 2023 | $0.73 | -89.0% |
| Q3 FY2022 | Oct 2, 2022 | $0.28 | -94.5% |
| Q2 FY2022 | Jul 3, 2022 | $0.36 | -20.0% |
| Q1 FY2022 | Apr 3, 2022 | $11.31 | – |
| Q4 FY2021 | Jan 2, 2022 | $6.61 | – |
| Q3 FY2021 | Oct 3, 2021 | $5.08 | – |
| Q2 FY2021 | Jul 4, 2021 | $0.45 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?